Aging Research Headlines
Humans Have Reached Their Lifespan Limits, Researchers Say
Researchers at the Albert Einstein College of Medicine say humans are reaching their natural biological limit. According to the report, scientific interventions would be required to extend the human lifespan beyond 125 years. The findings, published in Nature, analyzed aging in the United States, the United Kingdom, France, and Japan. To read the full report, go here.
NIH Almost Doubles Its Investment in BRAIN Initiative Research
The National Institutes of Health (NIH) recently announced its third round of grants for the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, bringing NIH's total 2016 investment to over $150 million. Over 100 new awards will assist NIH's efforts to develop new technologies that help "understand neural circuit function and capture a dynamic view of the brain in action." Read more here.
Cell Protein Could Deter Effects of Aging, Researchers Say
Researchers at The University of Nottingham say a cell protein could fight the effects of aging. The research focused on proteins that are called carbonic anhydrase found within the mitochondria. "What's really exciting about this development is that we have been able to surmise that the function of this protein is playing a role in the aging process within the cell," says Dr. Lisa Chakrabarti, one of the study's lead researchers. Read more here.
AFAR Scientific Director Lists Six Ways Research Is Changing Aging
Steven N. Austad, Ph.D., scientific director at the American Federation for Aging Research (AFAR), recently penned a blog post in the Huffington Post on AFAR's commitment to enhancing and prolonging healthspan. He also highlighted six ways AFAR's support of research has led to discoveries that help shape healthy aging. Read his post here.
ICYMI: Expert Q & A with Dr. Todd T. Brown on HIV and Aging Research
Check out our Healthspan Expert Q & A with Todd T. Brown, M.D., Ph.D., associate professor of Medicine and Epidemiology, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, about HIV and how it affects the healthspan of older adults. Read the Q & A here.
Maximizing the Value of Healthy Aging to Society, Bipartisan Policy Center, Washington, D.C., October 25
Join the Bipartisan Policy Center and the Alliance for Aging Research to explore the work of MetLife Foundation Silver Scholar Award® winner David A. Wise, the John F. Stambaugh Professor of Political Economy, Emeritus at the Harvard Kennedy School, and to discuss the broader issues of assessing value in aging. This award, administered by the Alliance for Aging Research, honors the work of researchers whose scholarship increases our understanding of the value of healthy life after 65 and continued medical innovations that help people live longer in good health.
As our population ages with increasing chronic disease, the U.S. faces enormous and unprecedented stresses to its health care system and economy. While many Americans age 65 and older are no longer in the "traditional" workforce, they are increasingly seeking opportunities for civic engagement, exploring new careers, supporting families, and continuing to contribute to society. Education, wealth, and health all increase the opportunities for older Americans to make continued societal contributions post-retirement.
To learn more about this event, go here.
Progeria Research Foundation Seeks Proposals for Research on Hutchinson-Gilford Progeria Syndrome, March 21, 2017
The Progeria Research Foundation (PRF) is the only organization in the world dedicated to discovering treatments and the cure for Progeria and its aging-related disorders. Progeria is a rare, fatal, "premature aging" disease that affects children, who die of heart disease (heart attacks or stroke) at an average of 14 years - the same heart disease that affects millions of normal aging adults.
PRF encourages proposals in the areas listed below. Investigators are not limited to applications that address these priorities, but rather are encouraged to use them to better understand the needs of the field at this time.
PRF is seeking proposals that address the following priorities:
1. Discovery of biological markers of disease in HGPS that can be assessed in human and/or mouse samples. Highest priority will be given to those markers that can be assayed in easily obtainable human samples such as blood, urine, and cheek swabs. In addition, proposals that explore biomarker relevance to disease process and /or change in markers with disease treatment are encouraged.
2. Discovery and/or testing of candidate treatment compounds in both cell based and mouse models of HGPS. Of note, proposals should test compounds in a progerin-producing mouse model as the priority. Comparisons to other mouse models of disease, such as ZMPSTE24 -/- and other non-progerin producing mouse models is acceptable, but only as a comparison to progerin-producing models.
Visit the PRF website for complete program information.